Cargando…

Exploring content and psychometric validity of newly developed assessment tools for itch and skin pain in atopic dermatitis

BACKGROUND: Atopic dermatitis (AD) is a common skin disorder characterized by chronic inflammation, altered skin barrier function, and inflammatory cell skin infiltration that decreases health-related quality of life (HRQoL). The study objective was to understand the patient perspective of AD burden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Newton, Louise, DeLozier, Amy M., Griffiths, Philip C., Hill, Jennifer N., Hudgens, Stacie, Symonds, Tara, Gable, Jonathon C., Paik, Jim, Wyrwich, Kathleen W., Eichenfield, Lawrence F., Abetz-Webb, Linda, Silverberg, Jonathan I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635522/ https://www.ncbi.nlm.nih.gov/pubmed/31312940 http://dx.doi.org/10.1186/s41687-019-0128-z

Ejemplares similares

Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermatitis
por: Silverberg, Jonathan I., et al.
Publicado: (2021)

The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA‐AD™): a clinical outcome measure for the severity of atopic dermatitis
por: Simpson, Eric L., et al.
Publicado: (2022)

How to measure itch in atopic dermatitis?
por: Oosterhaven, J.A.F.
Publicado: (2020)

Itch in Atopic Dermatitis – What Is New?
por: Legat, Franz J.
Publicado: (2021)

Neuroimmune interactions in chronic itch of atopic dermatitis
por: Yosipovitch, G., et al.
Publicado: (2019)

Intractable Itch in Atopic Dermatitis: Causes and Treatments
por: Umehara, Yoshie, et al.
Publicado: (2021)

Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis
por: Paller, Amy S., et al.
Publicado: (2022)

Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany
por: WEISSHAAR, Elke, et al.
Publicado: (2023)

Brain Processing of Contagious Itch in Patients with Atopic Dermatitis
por: Schut, Christina, et al.
Publicado: (2017)

Current Clinical Options for the Management of Itch in Atopic Dermatitis
por: Lipman, Zoe M, et al.
Publicado: (2021)

Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial
por: Reich, Kristian, et al.
Publicado: (2020)

Breaking the Itch–Scratch Cycle: Topical Options for the Management of Chronic Cutaneous Itch in Atopic Dermatitis
por: Harrison, Ian P., et al.
Publicado: (2019)

Neural Oscillation Associated with Contagious Itch in Patients with Atopic Dermatitis
por: Lee, In-Seon, et al.
Publicado: (2021)

The Pathology of Type 2 Inflammation-Associated Itch in Atopic Dermatitis
por: Moniaga, Catharina Sagita, et al.
Publicado: (2021)

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate‐to‐severe atopic dermatitis from the BREEZE‐AD7 Phase 3 randomized trial
por: Wollenberg, A., et al.
Publicado: (2021)

Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis
por: Yosipovitch, G., et al.
Publicado: (2019)

Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis
por: Walsh, Carolyn M, et al.
Publicado: (2019)

Is Itch Intensity in Atopic Dermatitis Associated with Skin Colonization by Staphylococcus aureus?
por: Blicharz, Leszek, et al.
Publicado: (2020)

An Altered Skin and Gut Microbiota Are Involved in the Modulation of Itch in Atopic Dermatitis
por: Moniaga, Catharina Sagita, et al.
Publicado: (2022)

What’s New in Topicals for Atopic Dermatitis?
por: Kleinman, Elana, et al.
Publicado: (2022)

Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical Trials
por: Silverberg, Jonathan I., et al.
Publicado: (2021)

Psychometric properties of morning joint stiffness duration and severity measures in patients with moderately to severely active rheumatoid arthritis
por: Bacci, Elizabeth D., et al.
Publicado: (2017)

The Role of the Microbiome and Microbiome-Derived Metabolites in Atopic Dermatitis and Non-Histaminergic Itch
por: Li, Wei, et al.
Publicado: (2020)

Molecular and cellular mechanisms of itch and pain in atopic dermatitis and implications for novel therapeutics
por: Kwatra, Shawn G, et al.
Publicado: (2022)

IL‐20 promotes cutaneous inflammation and peripheral itch sensation in atopic dermatitis
por: Lu, Zhiping, et al.
Publicado: (2022)

The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase III trials
por: Yosipovitch, Gil, et al.
Publicado: (2022)

Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families
por: Simpson, Eric L., et al.
Publicado: (2018)

The relationship between atopic dermatitis and atopic itch in children and the psychosocial functioning of their mothers: A cross-sectional study
por: Kobusiewicz, Aleksandra K., et al.
Publicado: (2023)

Associations between atopic dermatitis and other disorders
por: Silverberg, Jonathan I.
Publicado: (2018)

CROSS-CULTURAL ADAPTATION AND VALIDATION OF THE ITCHING SEVERITY SCALE IN CHILDREN AND ADOLESCENTS WITH ATOPIC DERMATITIS
por: Bruscky, Dayanne Mota Veloso, et al.
Publicado: (2017)

Itch Relief in Atopic Dermatitis: Comparison of Narrowband Ultraviolet B Radiation and Cyclosporine Treatment
por: JAWOREK, Andrzej, et al.
Publicado: (2020)

Phenotypic differences of atopic dermatitis stratified by age
por: Chatrath, Sheena, et al.
Publicado: (2022)

Compound traditional Chinese medicine dermatitis ointment ameliorates inflammatory responses and dysregulation of itch-related molecules in atopic dermatitis
por: Zhang, Rongrong, et al.
Publicado: (2022)

Debates in allergy medicine: Specific immunotherapy in children with atopic dermatitis, the “con” view
por: Ginsberg, David N., et al.
Publicado: (2016)

Psychometric properties of the single-item measure, severity of worst tiredness, in patients with moderately to severely active rheumatoid arthritis
por: Bacci, Elizabeth D., et al.
Publicado: (2017)

Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate‐to‐severe atopic dermatitis
por: Puelles, J., et al.
Publicado: (2021)

Evaluation of Itch by Using NC/NgaTnd Mice: A Model of Human Atopic Dermatitis
por: Tanaka, Akane, et al.
Publicado: (2011)

Association of Exposure to Wildfire Air Pollution With Exacerbations of Atopic Dermatitis and Itch Among Older Adults
por: Fadadu, Raj P., et al.
Publicado: (2022)

Crisaborole Inhibits Itch and Pain by Preventing Neutrophil Infiltration in a Mouse Model of Atopic Dermatitis
por: PAVLENKO, Darya, et al.
Publicado: (2023)

Food allergy testing in atopic dermatitis
por: Ramírez-Marín, Hassiel A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jhlfoo0enb0ck69gfdc53djcur